Lonza, GE creating Chinese biologics facility

Swiss company Lonza Group Ltd. (SIX:LONN) and the GE Healthcare unit of General Electric Co. (NYSE:GE) will build a biologics facility by 2020 in Guangzhou, China. The facility will be based on GE Healthcare's off-the-shelf biologics factory, KUBio, and enable Lonza to offer antibody development services and GMP manufacturing...